719 results about "Sleep apnea" patented technology

A method of treating obstructive sleep apnea includes providing an elongated element having a central buttress area and first and second arms extending from opposite ends of the central buttress area. The method includes implanting the central buttress area in a tongue so that a longitudinal axis of the central buttress area intersects an anterior-posterior axis of the tongue. The first and second arms are advanced through the tongue until the first and second arms engage inframandibular musculature. Tension is applied to the first and second arms for pulling the central buttress area toward the inframandibular musculature for moving a posterior surface of the tongue away from an opposing surface of a pharyngeal wall. The first and second arms are anchored to the inframandibular musculature for maintaining a space between the posterior surface of the tongue and the opposing surface of the pharyngeal wall.

An apnea monitor and system for treatment includes a detector in a fixed console that projects a detection beam at a sleep surface. The detection beam is reflected off a patient on the surface and return light is analyzed to develop a signal which varies with external motion of the patient's upper body. The motion signals are then fed to a pattern recognizer which identifies breath signals and analyzes them to detect cessation or excessive pauses in breathing, and trigger an alarm or intervention to restore breathing regularity. The monitor includes a laser for generating radiation. The radiation is reflected from the patient and is directed onto a detector. The detector produces output signals corresponding to the impinging reflected light, which are processed by a control element to determine the change of movement, e.g., the breathing rate, of the patient.

An implantable cardiac stimulation device comprises a metabolic demand sensor, an activity sensor, and one or more pulse generators. The metabolic demand sensor and activity sensor can sense metabolic demand and physical activity parameters, respectively. The pulse generators can generate cardiac pacing pulses with timing based on a comparison of the metabolic demand and physical activity parameters. The timed cardiac pacing pulses can prevent a sleep apnea condition.

The present invention provides systems and methods for selectively applying electrical energy to a target location within the head and neck of a patient's body, particularly including tissue in the ear, nose and throat. The present invention applies high frequency (RF) electrical energy to one or more electrode terminals in the presence of electrically conductive fluid to remove and / or modify the structure of tissue structures. The present invention is particularly useful for treating sleep obstructive disorders, such as sleep apnea and snoring.

A system and method for detecting, monitoring and analyzing physiological characteristics. Signals from a subject are acquired from a suite of sensors, such as temperature, carbon dioxide, humidity, light, movement, electromagnetic and vibration sensors, in a passive, non-invasive manner. The signals are processed, and physiological characteristics are isolated for analysis. The system and method are to analyze sleep patterns, as well as to prevent bed sores or detect conditions such as illness, restless leg syndrome, periodic leg movement, sleep walking, or sleep apnea. However, numerous other applications of the invention are also disclosed.

Headwear is adapted for use by a patient to position airway tubes of a nasal interface operatively connected to a positive airway pressure device. The headwear includes an elongated head strap for being worn around a head of the patient. Cooperating sets of front and rear tube holders are attached to the head strap, and are adapted for engaging and holding respective airway tubes of the nasal interface to retain the tubes in a desired position during use. The tube holders include at least one elastic strip extending along a longitudinal dimension of the head strap.

The ventilation interface for sleep apnea therapy interfaces a ventilation device to the patient's airways. The ventilation interface includes a pair of nasal inserts made from flexible, resilient silicone which are oval shaped in cross-section and slightly tapered from a base proximal the ventilation supply to the distal tip end. A bead flange is disposed about the exterior of each insert at the distal end of the insert. In one embodiment, a valve is disposed between the nasal inserts and a source of positive airway pressure, the valve having a rim with a one-way diaphragm pivotally attached to the valve body with an inflatable bladder depending from the rim which seals against an exit port during inspiration and deflates to uncover the exit port on expiration. Another embodiment has nasal inserts without positive airway pressure but with a removable filter in the inserts for filtering inspired air.

In a technique for collecting and analyzing physiological signals to detect sleep apnea, a small light-weight physiological monitoring system, affixed to a patient's forehead, detects and records the pulse, oximetry, snoring sounds, and head position of a patient to detect a respiratory event, such as sleep apnea. The physiological monitoring system may contain several sensors including a pulse oximeter to detect oximetry and pulse rate, a microphone to detect snoring sounds, and a position sensor to detect head position. The physiological monitoring system also can contain a memory to store or record the signals monitored by the mentioned sensors and a power source. The physiological monitoring system may be held in place by a single elastic strap, thereby enabling a patient to use the system without the assistance of trained technicians.

A method and apparatus for treating a breathing disorder and, more particularly, a method and apparatus for providing a pressurized air flow to an airway of a patient to treat congestive heart failure in combination with Cheyne-Stokes respiration and / or sleep apnea or other breathing disorders. A positive airway pressure ventilator is utilized in combination with an algorithm that adjusts IPAP and EPAP in order to counter a Cheyne-Stokes breathing pattern. Cheyne-Stokes respiration is detected by monitoring a peak flow of the patient.

Apparatus for fitting to the head of a patient for supply of gas to the nose at a positive pressure for treatment of snoring and sleep apnea comprises headgear for fitting to the head of a patient. A mask support forms part of said headgear and is held, in use, by portions of said headgear in a stable position above the nose of the patient. The mask support includes a manifold chamber, a first connector opening above said manifold chamber for attachment of a gas supply line and a second connector depending from said manifold chamber. The above apparatus may be used with a novel nasal mask which is a nares seal that may be removably connected to said second connector by a third connector forming part of said seal and having an air orifice formed therethrough. The seal further comprises first and second laterally spaced delivery tubes connecting with said air orifice and defining between them a generally triangular open space which extends, when in use, downwardly to a point below the nose of a patient. The delivery tubes thence curves inwardly and upwardly to approach the nose of a patient and supports first and second nostril tubes connected with said delivery tubes for insertion into the nares of a patient. Wire support for said laterally spaced tubes extends from the connector to about where said tubes curve inwardly and upwardly.

An apparatus is provided for controlling air supplied under pressure to a patient suffering from sleep disorders such as apnoea. The apparatus measures and / or calculates the inspiratory air flow, volume and pressure to the airway. Controlled pressurized air is supplied to the patient's upper anatomical airway, wherein the apparatus measures the air flow and pressure to the airway. The apparatus determines whether to increase or decrease the pressure to the patient's airway based on a determination of one or more factors, such as the occurrence of hypopnoea, hyperventilation, obstructive or central apnoea, air leakage and acoustical vibrations. Occurrences of events representing a sleep problem may be stored by the apparatus and retrieved by a clinician at a later date.

In a technique for collecting and analyzing physiological signals to detect sleep apnea, a small light-weight physiological monitoring system, affixed to a patient's forehead, detects and records the pulse, oximetry, snoring sounds, and head position of a patient to detect a respiratory event, such as sleep apnea. The physiological monitoring system may contain several sensors including a pulse oximeter to detect oximetry and pulse rate, a microphone to detect snoring sounds, and a position sensor to detect head position. The physiological monitoring system also can contain a memory to store or record the signals monitored by the mentioned sensors and a power source. The physiological monitoring system may be held in place by a single elastic strap, thereby enabling a patient to use the system without the assistance of trained technicians.

An implantable cardiac stimulation device comprises a physiologic sensor and one or more pulse generators. The physiologic sensor is capable of sensing a physiologic parameter. The pulse generators can generate cardiac pacing pulses with a timing based on the physiologic parameter. The timed cardiac pacing pulses can prevent a sleep apnea condition. In one example, a cardiac stimulation device has a physiologic sensor and can be configured to pace a patient's heart according to a rest mode of operation. The cardiac stimulation device uses measurements from the physiologic sensor to prevent and treat sleep apnea using a revised rest mode of operation. The revised rest mode operates under a presumption that sleep apnea is primary to a reduced heart rate, rather than secondary, so that pacing at a rate higher than the natural cardiac rate during sleep will prevent sleep apnea.

A cardiac stimulation device uses dynamic overdrive pacing to prevent sleep apnea. In another aspect, the device can use dynamic overdrive pacing to terminate sleep apnea after detection. An implantable cardiac stimulation device comprises a sensor and one or more pulse generators. The sensor senses intrinsic cardiac electrical phenomena. The pulse generators can generate cardiac pacing pulses with timing based on the sensed intrinsic cardiac electrical phenomena to dynamically overdrive the intrinsic cardiac electrical phenomena. The timed cardiac pacing pulses can prevent a sleep apnea condition.

An implantable cardiac stimulation device comprises a physiologic sensor and one or more pulse generators. The physiologic sensor is capable of sensing a physiologic parameter. The pulse generators can generate cardiac pacing pulses with a timing based on the physiologic parameter. The timed cardiac pacing pulses can prevent a sleep apnea condition. In one example, a cardiac stimulation device has a physiologic sensor and can be configured to pace a patient's heart according to a rest mode of operation. The cardiac stimulation device uses measurements from the physiologic sensor to prevent and treat sleep apnea using a revised rest mode of operation. The revised rest mode operates under a presumption that sleep apnea is primary to a reduced heart rate, rather than secondary, so that pacing at a rate higher than the natural cardiac rate during sleep will prevent sleep apnea.

Devices, systems and methods of neurostimulation for treating obstructive sleep apnea. The system is adapted to send an electrical signal from an implanted neurostimulator through a stimulation lead to a patient's nerve at an appropriate phase of the respiratory cycle based on input from a respiration sensing lead. External components are adapted for wireless communication with the neurostimulator. The neurostimulator is adapted to deliver therapeutic stimulation based on inputs.

A method and device for creating an afferent stimulus for preventing obstructive sleep apnea are disclosed. The device includes at least one electrode and a stimulator, of which at least one electrode stimulates the genioglossus muscle of a patient having obstructive sleep apnea. The electrode is capable of conducting selected electrical stimulation generated by the stimulator, and the system is capable of delivering the selected electrical stimulation during a selected time of day. The electrical stimulation is selected to maintain sufficient muscle tone of the genioglossus muscle to prevent it from obstructing the airway during sleep, preferably at a stimulus intensity low enough to avoid awakening the patient during sleep. A removable mouthpiece having a battery, at least one electrode, and a controller, and optionally a sensor, can be used for providing the stimulation.

A method for monitoring the progression of the hemodynamic status of a patient by tracking autonomic tone. For example, the method may be applied to patients suffering from heart failure, diabetic neuropathy, cardiac ischemia, sleep apnea and hypertension. An implantable or other ambulatory monitor senses a pulse amplitude signal such as a vascular plethysmography signal. Variations of the signal amplitude on a scale greater than the heartbeat to heartbeat scale are indicative of variations in autonomic tone. A significant reduction in pulse amplitude and pulse amplitude variability are indicative of a heart failure exacerbation or other disease state change. This information may be used to warn the patient or healthcare providers of changes in the patient's condition warranting attention.

A medical apparatus and method for medical patients that suffer from Sleep Apnea. A breathing mask that fits comfortably over a nose area. Because a mask is shaped to a face, it is less bulky and cumbersome over the nose area. Inside a shell of a mask, towards a patients' face, is a silicone wax lining that is on the inner rim of a shell and parameters to enclose a nose as a seal. A silicone wax substance is novel to a device because of its ability to retain a form it has been molded into. A silicone wax lining around a nose allows a patient to form and mold a substance against a face and provide an air-tight seal. A single strap is used to fasten and secure a mask to a face. Tabs or buckle can be used to fasten a strap.

Embodiments of the invention relate to a mask assembly for use in treatment systems for treating obstructive sleep apnea using continuous positive air pressure (CPAP). The mask assembly comprises a mask or nasal interface for supplying gas to the nose of a wearer of the mask assembly. The mask assembly also comprises a strap or harness attached to the mask for securing the mask assembly to the wearer and sensors located on the mask assembly for measuring physiological signals of the wearer. These physiological signals are communicated to a monitoring unit which, in association with a CPAP device, serves to determine the efficacy of the CPAP treatment and to vary operational parameters of the treatment.

Headwear is adapted for use by a patient to position airway tubes of a nasal interface operatively connected to a positive airway pressure device. The headwear includes an elongated head strap for being worn around a head of the patient. First and second tube holders are attached to the head strap, and adapted for engaging and holding respective airway tubes of the nasal interface to retain the tubes in a desired position during use. Each of the tube holders includes an elastic strip extending along a longitudinal dimension of the head strap. The elastic strip cooperates with the head strap to form an eye for receiving an airway tube of the nasal interface.

Described herein are nasal respiratory devices and methods for treating a variety of medical diseases including snoring and sleep apnea through the use of such devices. In general, these devices include an airflow resistor, such as a flap valve and a holdfast for securing the device in communication with the subject's nasal cavity. The devices may be configured to include leak paths to regulate the expiratory pressure when worn by a subject. Methods for using these devices may include securing a device over or at least partially within (or both of) a subject's nasal cavities.

Systems and methods provide a self-contained, intermittent positive airway pressure system for treating sleep apnea, snoring, and other respiratory disorders. The systems and methods provide an air flow director that can be worn in or over the nose of the individual in communication with an upper airway. The systems and methods provide an airflow regulation assembly that can also be worn in its entirety by the individual in communication with the air flow director. The airflow regulation assembly includes a source of positive pressure. The airflow regulation assembly intermittently operates the source of positive pressure to increase positive air pressure in the air flow director sufficient to resist tissue collapse in the upper airway during only a portion of the respiratory cycle less than the entire respiratory cycle.

Headwear is adapted for use by a patient to position airway tubes of a nasal interface operatively connected to a positive airway pressure device. The headwear includes an elongated head strap for being worn around a head of the patient. First and second tube holders are attached to the head strap, and adapted for engaging and holding respective airway tubes of the nasal interface to retain the tubes in a desired position during use. Each of the tube holders includes an elastic strip extending along a longitudinal dimension of the head strap. The elastic strip cooperates with the head strap to form an eye for receiving an airway tube of the nasal interface.

Apparatus for providing positive pressure for treatment of snoring and sleep apnea are disclosed. The apparatus includes a nares seal configured to engage the nares of a patient and to direct pressurized air into the airways of the patient. The nares seal can include first and second laterally spaced delivery tubes defining a generally triangular open space between them. The delivery tubes can extend downward below the nose of a patient and curve inward and upward under the nose of the patient. A first and a second nostril tube are connected to the delivery tubes for insertion into the nares of the patient. A wire support may be provided in each of the laterally spaced delivery tubes. The nares seal may be connected to a mask support of headgear configured to be secured to the head of the patient.

The present invention provides a method and apparatus for detecting and monitoring obstructive sleep apnea. The apparatus includes an intracardiac impedance sensor to measure intracardiac impedance, a movement sensor to measure an amount of movement of a patient, and a controller operatively coupled to said intracardiac impedance sensor and said movement sensor, said controller adapted to receive at least one of an intracardiac impedance and the amount of movement of the patient and detect obstructive sleep apnea based upon said intracardiac impedance and said movement.

An apparatus for selectively positioning intraoral anatomic features of a human patient to enhance upper airway stability for use alone or in combination with positive airway pressure as therapeutic treatment for obstructive sleep apnea and other conditions, such as snoring, which are symptomatic of upper airway instability.